[ CAS No. 1002-62-6 ] {[proInfo.proName]}

Name: 1002-62-6|Sodium decanoate|98%
Brand: Ambeed
SKU: A509712
Price: 5.0 USD
Availability: InStock
Rating: 92 (27 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 1002-62-6 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 1002-62-6 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 1002-62-6 ]

SDS Specification

Alternatived Products of [ 1002-62-6 ]

Product Details of [ 1002-62-6 ]

CAS No. :	1002-62-6	MDL No. :	MFCD00066453
Formula :	C₁₀H₁₉NaO₂	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	FIWQZURFGYXCEO-UHFFFAOYSA-M
M.W :	194.25	Pubchem ID :	4457968
Synonyms :	Decanoic acid sodium;Decanoic Acid (sodium salt);Sodium-n-decanoate;Sodium decanoic acid;Sodium caprinate;Decanoic acid, sodium salt;Caprinic acid sodium salt;Capric acid, sodium salt;Sodium caprate;Decylic Acid;Capric Acid;C10:0	Chemical Name :	Sodium decanoate

Calculated chemistry of [ 1002-62-6 ]

Physicochemical Properties

Num. heavy atoms :	13
Num. arom. heavy atoms :	0
Fraction Csp3 :	0.9
Num. rotatable bonds :	8
Num. H-bond acceptors :	2.0
Num. H-bond donors :	0.0
Molar Refractivity :	50.01
TPSA :	40.13 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	Yes
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-4.58 cm/s

Lipophilicity

Log Po/w (iLOGP) :	-10.82
Log Po/w (XLOGP3) :	4.09
Log Po/w (WLOGP) :	1.88
Log Po/w (MLOGP) :	2.58
Log Po/w (SILICOS-IT) :	2.63
Consensus Log Po/w :	0.07

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.09
Solubility :	0.157 mg/ml ; 0.000807 mol/l
Class :	Soluble
Log S (Ali) :	-4.64
Solubility :	0.00447 mg/ml ; 0.000023 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-2.87
Solubility :	0.26 mg/ml ; 0.00134 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	3.0
Synthetic accessibility :	1.78

Safety of [ 1002-62-6 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 1002-62-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 1002-62-6 ]
Downstream synthetic route of [ 1002-62-6 ]

[ 1002-62-6 ] Synthesis Path-Upstream 1~1

1
[ 1002-62-6 ]
[ 2277-23-8 ]

Reference： [1] Fette und Seifen, 1955, vol. 57, p. 652,656[2] Grasas Aceites, 1956, vol. 7, p. 286,292

[ 1002-62-6 ] Synthesis Path-Downstream 1~55

1
[ 1948-40-9 ]
[ 2082-76-0 ]
[ 1002-62-6 ]
3<i>t</i>(?)-(4-hydroxy-3,5-diiodo-phenyl)-2-octyl-acrylic acid [ No CAS ]

Reference： [1]Patent: US2528542,1948,

2
[ 96-23-1 ]
[ 1002-62-6 ]
[ 17598-93-5 ]

Reference： [1]Fette und Seifen,1955,vol. 57,p. 652,656
Grasas Aceites,1956,vol. 7,p. 286,292

3
[ 1002-62-6 ]
[ 2277-23-8 ]

Reference： [1]Fette und Seifen,1955,vol. 57,p. 652,656
Grasas Aceites,1956,vol. 7,p. 286,292

4
[ 1002-62-6 ]
[ 86-52-2 ]
[ 71844-11-6 ]

Reference： [1],1958,vol. 6,p. 77,93
Chem.Abstr.,1959,p. 19987

5
[ 1002-62-6 ]
[ 824-55-5 ]
decanoic acid-(2,4-dimethyl-benzyl ester) [ No CAS ]

Reference： [1]Kogyo Kagaku zasshi / Journal of the Society of Chemical Industry,1953,vol. 56,p. 547
Chem.Abstr.,1954,p. 12454

6
[ 1002-62-6 ]
[ 112-31-2 ]

Reference： [1]Heterocycles,1988,vol. 27,p. 1595 - 1598

7
[ 1002-62-6 ]
[ 112-30-1 ]

Reference： [1]Journal of the Chemical Society. Chemical communications,1995,p. 439 - 440

8
[ 1956-09-8 ]
[ 1002-62-6 ]
[ 824-78-2 ]

Reference： [1]Journal of the American Chemical Society,1996,vol. 118,p. 12536 - 12540

9
[ 1002-62-6 ]
sodium p-benzoylbenzoate [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]

Reference： [1]Chemistry Letters,1999,p. 275 - 276

10
[ 1002-62-6 ]
sodium p-benzoylbenzoate [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]

Reference： [1]Chemistry Letters,1999,p. 275 - 276

11
[ 1002-62-6 ]
sodium p-benzoylbenzoate [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]
C₂₄H₂₈O₅^(2-)*2Na⁽¹⁺⁾ [ No CAS ]

Reference： [1]Chemistry Letters,1999,p. 275 - 276

14
[ 1002-62-6 ]
dil.H₂O₂ [ No CAS ]
[ 821-55-6 ]

Reference： [1]American Chemical Journal,1910,vol. 44,p. 49
Journ. of Biol. Chem.,vol. 8,p. 27
Chemisches Zentralblatt,1910,vol. 81,p. 990

15
[ 1002-62-6 ]
[ 16899-10-8 ]
[ 2034-55-1 ]
[ 1422-27-1 ]
8-hydroxydecanoic acid [ No CAS ]

Reference： [1]Advanced Synthesis and Catalysis,2002,vol. 344,p. 932 - 937

16
{μ-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(hexanoato-O)platinum(II)] tetranitrate [ No CAS ]
[ 1002-62-6 ]
{μ-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(caproato-O)platinum(II)] tetracaprate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
64%	In water; at 20℃; for 0.25h;	The reactions were carried out shielded from light and in MiIIiQ H2O. A solution of {mu-(l ,8, l l , 18-tetraazaoctadecane-N1,N18)bis[tralpha«5- diamino(caproato-O)platinum(II)] } tetranitrate of Example 1 (0.441 g, 0.368 mmoli) in H2O (25 mL) was added with a solution of <strong>[1002-62-6]sodium caprate</strong> (0.286 g, 1.472 mmoles) in H2O (5 mL) drop by drop and under stirring; the resulting mixture was kept under stirring at room temperature for 15 min. The gelly material which separated from the mixture was dissolved by addition of CHCl3 (25 mL). After stirring for 15 min. at room temperature, the organic <n="37"/>phase was separated from the aqueous one and evaporated to dryness at 350C under reduced pressure. The oily residue was solidified by treatment with Et2O and evaporation at 35C under reduced pressure. The solid was collected on a buchner filter and dried under vacuum at 35C to give 0.387 g (64% yield) of the title product.Elemental Calculated C 48.51% H 9.01% N 6.86% Pt 23.88% AnalysisFound C 48.09% H 8.99% N 6.62% Pt 23.31 %MS: 1 159.0, [MH+C3F7COOH-4C9H19COOH]+ 1H NMR (CD3OD): delta 2.88 (4H, s); 2.73 (4H, t); 2.61 (4H, m); 2.19 (12H, m); 1.6 (18H, m); 1.41 (8H, m); 1.3 (58H, m); 0.9 (18H, m).
64%	In water; at 20℃; for 0.25h;Darkness;Product distribution / selectivity;	Example 11{mu-(1,8,11,18-Tetraazaoctadecane-N1,N18)bis[trans-diamino(caproato-O)platinum(II)]tetracaprate The reactions were carried out shielded from light and in MilliQ H2O. A solution of {mu-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(caproato-O)platinum(II)]tetranitrate of Example 1 (0.441 g, 0.368 mmoli) in H2O (25 mL) was added with a solution of <strong>[1002-62-6]sodium caprate</strong> (0.286 g, 1.472 mmoles) in H2O (5 mL) drop by drop and under stirring; the resulting mixture was kept under stirring at room temperature for 15 min. The gelly material which separated from the mixture was dissolved by addition of CHCl3 (25 mL). After stirring for 15 min. at room temperature, the organic phase was separated from the aqueous one and evaporated to dryness at 35 C. under reduced pressure. The oily residue was solidified by treatment with Et2O and evaporation at 35 C. under reduced pressure. The solid was collected on a buchner filter and dried under vacuum at 35 C. to give 0.387 g (64% yield) of the title product. Elemental Calculated C 48.51% H 9.01% N 6.86% Pt 23.88% Analysis Found C 48.09% H 8.99% N 6.62% Pt 23.31% MS: 1159.0, [MH+C3F7COOH-4C9H19COOH]+ 1H NMR (CD3OD): delta 2.88 (4H, s); 2.73 (4H, t); 2.61 (4H, m); 2.19 (12H, m); 1.6 (18H, m); 1.41 (8H, m); 1.3 (58H, m); 0.9 (18H, m).

Reference： [1]Patent: WO2007/71415,2007,A1 .Location in patent: Page/Page column 35-36
[2]Patent: US2010/292322,2010,A1 .Location in patent: Page/Page column 15

17
[ 334-48-5 ]
[ 1002-62-6 ]

Yield	Reaction Conditions	Operation in experiment
87%	With sodium hydrogencarbonate; In ethanol; water; for 12h;Heating / reflux;	Example 1: Sodium Decanoate (Capric Acid Sodium Salt : N=8) To a twelve-liter three-necked flask equipped with a thermometer, mechanical stirrer, and a reflux condenser, were added decanoic acid (500 g, 2.9 mole) and absolute ethanol (5.5 L). The mixture was stirred vigorously for 5 minutes. The clear solution was then diluted with water (275 ml). Solid sodium bicarbonate (218 g, 2.6 mole) was added in one portion and the resulting suspension heated under reflux for 12 hours. At the end of the reaction the pH was observed to be neutral. The clear solution was then cooled slowly during 3 hours to 42 C under vigorous stirring. The resulting mixture was diluted with tert-butyl methyl ether (1.1 L) and stirring was continued for an additional 4 hours. The temperature dropped to 30 C. The white precipitate was filtered under suction (water aspirator) using a polypropylene coarse glass funnel (7 L) and the wet solid was air-dried for 1.5 hours. The product was broken up into small pieces using a spatula and kept under high vacuum at 20 C for 16 hours.
	With sodium hydroxide;	Capric acid was manufactured using palm oil as the starting material. The capric acid was mixed with a NaOH solution. This solution was spray dried to obtain a sodium caprate powder. Finally, the spray dried sodium caprate was dry granulated using a roller compactor.

Reference： [1]Organic Process Research and Development,2009,vol. 13,p. 581 - 583
[2]Patent: WO2005/12217,2005,A2 .Location in patent: Page/Page column 3 - 4
[3]Patent: WO2014/191545,2014,A1 .Location in patent: Page/Page column 38

18
acetone - water [ No CAS ]
diisopropyl ether-n-hexane [ No CAS ]
[ 95498-97-8 ]
[ 1002-62-6 ]
[ 95499-11-9 ]

Yield	Reaction Conditions	Operation in experiment
		EXAMPLE 11 16beta-Ethyl-17beta-n-decanoyloxyacetoxy-4-estren-3-one To 200 ml of acetone-water (1:1) are added 6.0 g of 16beta-ethyl-17beta-bromoacetoxy-4-estren-3-one and 5.2 g of sodium n-decanoate and the mixture is refluxed for 10 hours. The solvent is distilled off under reduced pressure and the residue is extracted with 300 ml of ethyl acetate. The organic layer is separated, washed with water and saturated aqueous sodium chloride solution and dried over anhydrous sodium sulfate. The solvent is then distilled off under reduced pressure and the residue is subjected to column chromatography. Following passage of 750 ml of diisopropyl ether-n-hexane (1:9), elution is carried out with 1000 ml of a 1:1 mixture of the same solvents. The elude is evaporated under reduced pressure to remove the solvent, giving 5.2 g of the above-identified compound as a light-yellow viscous oil. IR (filmliquid) cm-1: 1750, 1740, 1685, 1670, 1615. NMR(CDCl3)delta: 0.84 (s, C13 -CH3), 0.87 (t, J=6 Hz, C16 -CH2 CH3), 0.92 (t, J=6 Hz, CH3), 1.27 (b-s, CH2 *7), 2.40 (t, J=6 Hz, CH2 CO), 0.6-2.7 (m, steroid nucleus CH, CH2), 4.61 (s, OCH2 CO), 4.78 (d, J=9 Hz, C17 -alphaH), 5.81 (s, C4 -H). Elemental analysis: Calcd. for C32 H50 O5.1/2H2 O: C, 73.38; H, 9.81. Found: C, 73.45; H, 9.48.

Reference： [1]Patent: US4609650,1986,A

19
uranyl(VI) nitrate [ No CAS ]
[ 1002-62-6 ]
uranyl decanoate [ No CAS ]

Reference： [1]Recueil des Travaux Chimiques des Pays-Bas,1988,vol. 107,p. 310 - 312

20
[ 1002-62-6 ]
copper(II) nitrate [ No CAS ]
[ 10139-56-7 ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

21
[ 15654-71-4 ]
[ 1002-62-6 ]
trans-dicapratobis(ethylenediamine)chromium(III) perchlorate [ No CAS ]

Reference： [1]Bulletin of the Chemical Society of Japan,1962,vol. 35,p. 901 - 904
[2]Gmelin Handbuch der Anorganischen Chemie,Gmelin Handbook: Cr: MVol.C, 90, page 207 - 209

22
[ 10196-18-6 ]
[ 1002-62-6 ]
[ 13040-17-0 ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

23
[ 1002-62-6 ]
[ 7646-85-7 ]
[ 13040-17-0 ]

Reference： [1]Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy,2008,vol. 70,p. 195 - 197

24
{Pd(C10H21OC6H3CH=NN=CHC6H4OC10H21)(μ-Cl)}2 [ No CAS ]
[ 1002-62-6 ]
[ 127421-31-2 ]

Reference： [1]Organometallics,1990,vol. 9,p. 2028 - 2033

25
{Pd(C10H21OC6H3CH=NN=CHC6H4OC10H21)(μ-Cl)}2 [ No CAS ]
[ 1002-62-6 ]
silver perchlorate [ No CAS ]
[ 127421-31-2 ]

Reference： [1]Organometallics,1990,vol. 9,p. 2028 - 2033

26
manganese(II) nitrate [ No CAS ]
[ 1002-62-6 ]
manganese(II) decanoate [ No CAS ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

27
thorium(IV) nitrate [ No CAS ]
[ 1002-62-6 ]
thorium caprate [ No CAS ]

Reference： [1]Journal of the Indian Chemical Society,1987,vol. 64,p. 285 - 288

28
[ 1002-62-6 ]
[ 7758-99-8 ]
copper(II) decanoate [ No CAS ]

Reference： [1]Thermochimica Acta,1997,vol. 302,p. 35 - 39

29
[ 1002-62-6 ]
cadmium(II) nitrate [ No CAS ]
cadmium(II) decanoate [ No CAS ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

30
copper hydroxide acetate monohydrate [ No CAS ]
[ 1002-62-6 ]
2Cu⁽²⁺⁾*3OH^(1-)*CH₃(CH₂)8COO^(1-) = Cu₂(OH)3(CH₃(CH₂)8COO) [ No CAS ]

Reference： [1]Inorganic Chemistry,1996,vol. 35,p. 1915 - 1917

31
[ 1002-62-6 ]
cobalt(II) nitrate [ No CAS ]
[ 2269-64-9 ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

32
[ 1002-62-6 ]
silver nitrate [ No CAS ]
[ 13126-67-5 ]

Reference： [1]Chemistry Letters,2004,vol. 33,p. 158 - 159

33
[ 1002-62-6 ]
nickel(II) nitrate [ No CAS ]
nickel(II) decanoate [ No CAS ]

Reference： [1]Russian Journal of Inorganic Chemistry,2004,vol. 49,p. 1440 - 1443

34
europium hydroxynitrate hydrate [ No CAS ]
[ 1002-62-6 ]
[ 7732-18-5 ]
europium hydroxy(decanoate) sesquihydrate [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2009,p. 929 - 936

35
2Nd⁽³⁺⁾*5OH^(1-)*NO₃^(1-)*H₂O=Nd₂(OH)5(NO₃)*H₂O [ No CAS ]
[ 1002-62-6 ]
Nd₂(OH)5(decanoate)(decanoic acid)0.55*H₂O [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2009,p. 4727 - 4732

36
2La⁽³⁺⁾*5OH^(1-)*NO₃^(1-)*1.5H₂O=La₂(OH)5(NO₃)*1.5H₂O [ No CAS ]
[ 1002-62-6 ]
La₂(OH)5(decanoate)(decanoic acid)0.60*H₂O [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2009,p. 4727 - 4732

37
bis{trans(diammine)(chloro)platinum (II)}-μ-(1,16-diamino-7,10-diazahexadecane-N1,N16) dinitrate [ No CAS ]
[ 1002-62-6 ]
{μ-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(decanoato-O)platinum(II)] tetradecanoate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
19%		The reactions were carried out shielded from light and in MiIIiQ H2O. A solution of { mu-( 1,8, 1 1, 18-tetraazaoctadecane-N1,N18)bis[7r««.y- diamino(dichloro)platinum(II)] } tetranitrate (0.2 g, 0.193 mmoles) in H2O (18 mL) was added with AgNO3 (0.0655 g, 0.386 mmoles) and the resulting suspension was left under stirring at room temperature for 24 hours. The solid was removed filtering the mixture twice over a double microfiber filter; the filter was washed with 1 mL of H2O which was pooled with the filtrate. The filtrate was added drop by drop and under stirring to a <strong>[1002-62-6]sodium decanoate</strong> (0.225 g, 1.158 mmoles) solution in H2O (30 mL); the resulting mixture was kept under stirring at room temperature for 6 days. After decantation of the solvent, the sticky material was partitioned between CHCl3 (20 mL) and H2O (20 mL) and the solid undissolved in the diphasic system was removed by filtration. The organic phase was separated from the aqueous one and <n="32"/>evaporated to dryness (350C) under reduced pressure; the sticky residue solidified by suspension in Et2O, which was then evaporated (350C) under reduced pressure. The resulting solid was collected and dried under vacuum at 35C to give 0.064 g (19% yield) of a brown powder.Elemental Calculated C 50 .90% H 9 .35% N 6 .42%AnalysisFound C 48 .88% H 9 .66% N 6 .61 %MS: 1 171.4, [MH+CF3COOH-4C9H,9COOH]+ 1H NMR (CDCl3): delta 6.25 (4H, s); 4.45 (12H, s); 2.90 (4H, s); 2.70 (8H, m); 2.15 (12H, m); 1.54 (2OH, m); 1.26 (8OH, m); 0.87 (18H, m).

Reference： [1]Patent: WO2007/71415,2007,A1 .Location in patent: Page/Page column 30-31

38
bis{trans(diammine)(chloro)platinum (II)}-μ-(1,16-diamino-7,10-diazahexadecane-N1,N16) dinitrate [ No CAS ]
[ 1002-62-6 ]
{μ-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(decanoato-O)platinum(II)]tetradecanoate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
19%		Example 7{mu-(1,8,11,18-Tetraazaoctadecane-N1,N18)bis[trans-diamino(decanoato-O)platinum(II)]tetradecanoate The reactions were carried out shielded from light and in MilliQ H2O. A solution of {mu-(1,8,11,18-tetraazaoctadecane-N1,N18)bis[trans-diamino(dichloro)platinum(II)]tetranitrate (0.2 g, 0.193 mmoles) in H2O (18 mL) was added with AgNO3 (0.0655 g, 0.386 mmoles) and the resulting suspension was left under stirring at room temperature for 24 hours. The solid was removed filtering the mixture twice over a double microfiber filter; the filter was washed with 1 mL of H2O which was pooled with the filtrate. The filtrate was added drop by drop and under stirring to a <strong>[1002-62-6]sodium decanoate</strong> (0.225 g, 1.158 mmoles) solution in H2O (30 mL); the resulting mixture was kept under stirring at room temperature for 6 days. After decantation of the solvent, the sticky material was partitioned between CHCl3 (20 mL) and H2O (20 mL) and the solid undissolved in the diphasic system was removed by filtration. The organic phase was separated from the aqueous one and evaporated to dryness (35 C.) under reduced pressure; the sticky residue solidified by suspension in Et2O, which was then evaporated (35 C.) under reduced pressure. The resulting solid was collected and dried under vacuum at 35 C. to give 0.064 g (19% yield) of a brown powder. Elemental Calculated C 50.90% H 9.35% N 6.42% Analysis Found C 48.88% H 9.66% N 6.61% MS: 1171.4, [MH+CF3COOH-4C9H19COOH]+ 1H NMR (CDCl3): delta 6.25 (4H, s); 4.45 (12H, s); 2.90 (4H, s); 2.70 (8H, m); 2.15 (12H, m); 1.54 (20H, m); 1.26 (80H, m); 0.87 (18H, m).

Reference： [1]Patent: US2010/292322,2010,A1 .Location in patent: Page/Page column 12

39
[ 10196-18-6 ]
[ 1002-62-6 ]
[ 822-16-2 ]
Zn⁽²⁺⁾*C₁₀H₁₉O₂^(1-)*C₁₈H₃₅O₂^(1-)=Zn(C₁₀H₁₉O₂)(C₁₈H₃₅O₂) [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2011,p. 1315 - 1321

40
[ 10196-18-6 ]
[ 1002-62-6 ]
[ 408-35-5 ]
[ 1280225-99-1 ]

Reference： [1]European Journal of Inorganic Chemistry,2011,p. 1315 - 1321

41
[ 10196-18-6 ]
[ 1002-62-6 ]
[ 822-12-8 ]
[ 1280225-98-0 ]

Reference： [1]European Journal of Inorganic Chemistry,2011,p. 1315 - 1321

42
[ 10196-18-6 ]
[ 1002-62-6 ]
[ 629-25-4 ]
Zn⁽²⁺⁾*C₁₀H₁₉O₂^(1-)*C₁₂H₂₃O₂^(1-)=Zn(C₁₀H₁₉O₂)(C₁₂H₂₃O₂) [ No CAS ]

Reference： [1]European Journal of Inorganic Chemistry,2011,p. 1315 - 1321

43
[ 1002-62-6 ]
[ 75-78-5 ]
[ 62267-06-5 ]

Yield	Reaction Conditions	Operation in experiment
	In n-heptane; water;	Example 1 Preparation of Di(decanoyloxy)dimethylsilane 0.012 mol dimethyldichlorosilane is added to 50ml anhydrous ether, to which is further added 0.02 mol <strong>[1002-62-6]sodium decanoate</strong> under agitation at 40C. To increase the yield, an excess of dimethyl dichlorosilane is added. This is followed by approximately another 3 hours of agitation at 40C. For hydrolysis of the excess dimethyldichlorosilane, water is added and approximately 10 ml ether is applied for extraction 3 to 5 times. The combined ether extracts are dried over anhydrous sodium sulphate and, after filtering off, evaporated in a vacuum. The remaining di(decanoyloxy)dimethylsilane is recrystalised from heptane.

Reference： [1]Patent: EP2384743,2011,A1

44
[ 1956-09-8 ]
[ 100-02-7 ]
[ 1002-62-6 ]

Reference： [1]Journal of Molecular Liquids,2012,vol. 169,p. 106 - 109

45
[ 17084-13-8 ]
6Zn⁽²⁺⁾*C₉₇H₉₁N₁₈O₃^(3-)*9NO₃^(1-) [ No CAS ]
[ 1002-62-6 ]
C₁₅₇H₂₀₅N₁₈O₁₅Zn₆⁽³⁺⁾*3F₆P^(1-) [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
35%	In methanol; at 5℃; for 24h;	Zn61(NO3)9 (25.0 mg, 0.1 mmol) was dissolved in methanol (2 mL), to which added were a methanolic solution (2 mL) of <strong>[1002-62-6]sodium decanoate</strong> (11.7 mg, 0.06 mmol) and subsequently a methanol solution of potassium hexafluorophosphate (2 mL) (5.5 mg, 0.03 mmol). The mixture was left for 24h at 5C, resulting in deposition of octahedral crystals (colorless to pale pink). The product was collected by filtration and dried under reduced pressure. Yield 12 mg (35%)

Reference： [1]Bulletin of the Chemical Society of Japan,2015,vol. 88,p. 698 - 705

46
C₂₀H₃₄I₄N₄Pt₂ [ No CAS ]
[ 1002-62-6 ]
C₆₀H₁₁₀N₄O₈Pt₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
55.8%		General procedure: To a stirred suspension of [Pt2I4L] (0.1775 g, 0.5 mmol) in solvent (50 ml of water and 50 ml of EtOH), a solution of AgNO3 (0.68 g, 4.0 mmol) in water (20 ml) was added. Under a nitrogen atmosphere, the mixture was heated at 50 C for 24 h in the dark and the resulting AgI deposit was removed by filtration. Then a suspension of the corresponding monocarboxylic acid sodium (4.0 mmol) aqueous solution was added to the filtrate. The mixture was stirred at 50 C for 24 h in the dark. The solution was obtainedsome light yellow solid crystallized in the process of cooling after concentration under vacuum. The resulting precipitate was collected by filtration, washed sequentially with water, ethanol and ether, and then dried at reduced pressure. The products A1-A2 were white solids and A3-A6 were light yellow solids.

Reference： [1]Inorganica Chimica Acta,2017,vol. 455,p. 166 - 172

47
[ 357625-50-4 ]
[ 1002-62-6 ]
C₁₃H₁₄N₃O₄S₂⁽¹⁺⁾*C₁₀H₁₉O₂^(1-)*C₁₀H₂₀O₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
5.4 g	In water; at 20℃; for 1h;	To a stined solution of <strong>[1002-62-6]sodium decanoate</strong> (5.1gm) in water (50m1), solution of 3-[2-(methylsulfonyl)hydrazinyl]carbonyl } -1- [2-oxo-2-(thiophen-2-yl)ethyl]pyridinium chloride(10 gm,) in water (100m1) was added at RT and stined for 1 hour. The separated solid was filtered, washed with water (100m1) and dried to give title compound (5.4gm) as solid.?H NMR (DMSO-d6, 400 MHz, ppm): 0.839-0.872(6H, multiplet), 1.242 (24H, multiplet),1.460-1.493 (4H, multiplet), 2.157-2.194(4H, triplet), 2.896-2.922 (1H, multiplet), 6.452(2H, broad multiplet), 7.336 (1H, broad multiplet), 8.064-8.211 (3H, broad multiplet), 8.890(2H, broad multiplet), 9.439 (1H, broad multiplet)IR (KBr): 2924cm?, 2853cm?, 1679cm?, 1336cm?

Reference： [1]Patent: WO2016/162785,2016,A1 .Location in patent: Page/Page column 24

48
[ 1002-62-6 ]
[ 633-65-8 ]
berberine decanoate ester [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In ethanol; water; for 0.5h;	Accurately weighed 1.0004 grams of berberine hydrochloride dihydrate dissolved in 500mL of distilled water and dubbed berberine hydrochloride saturated solution; Accurately weighed 0. 1229 grams of Sodium Decanoate dissolved in 4mL of distilled water; The aqueous solution of Sodium Decanoate was added dropwise in to the saturated solution of berberine hydrochloride under magnetic stirring, the molar ratio of Sodium Decanoate with berberine was 1: 3 and stirring was continued for 30 Min. Precipitate all precipitation, centrifugation, cleaning and collection of precipitation and freeze-drying was carried out to obtain Electrostatic complexes of berberine dodecyl sulfate ester

Reference： [1]Patent: CN102702190,2016,B .Location in patent: Paragraph 0022; 0023

49
C₂₀H₄₂N₄O₄Pt₂⁽⁴⁺⁾*4NO₃^(1-) [ No CAS ]
[ 1002-62-6 ]
C₆₀H₁₁₀N₄O₈Pt₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In ethanol; water;Inert atmosphere;	General procedure: D1, D2, D3, D4 and D5.To a stirred suspension of [PtLI](0.5 mmol) in solvent (50 ml of water and 50 ml of EtOH), a solution of AgNO3(4.0 mmol) in water (20 ml) was added. Under a nitrogen atmosphere, themixture was heated at 50 C for 12 h in the dark and the resulting AgI depositwas removed by filtration. Then corresponding sodium carboxylate (2.0 mmol)aqueous solution was added to the filtrate. The filtrate was evaporated tonearly dryness and some white solids precipitated, which were washed withwater and ethanol for several times, and dried in vacuum.Data for A1: Yield:34%

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 963 - 966

51
C₉H₁₉N₂O₃Pt⁽¹⁺⁾*NO₃^(1-) [ No CAS ]
[ 1002-62-6 ]
C₁₉H₃₆N₂O₄Pt [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In water; at 55℃; for 24h;Inert atmosphere; Darkness;	General procedure: Four millimole [PtRI] was suspended in 250 mL pure water and asolution of 4 mM AgNO3 in 80 mL pure water was added. After stirring under a nitrogenatmosphere in the dark for 24 h at 50 C, the precipitate was filtered off. Filtrate was blendedwith 4 mM CH3COONa and stirred at 55 C for 24 h. The solution was concentrated to 3 mL and then cooled to 0 C. A pale yellow powder was collected, washed with a small amountof chilled water and ethanol, and then dried at 60 C in vacuum. Yield 23.6%.

Reference： [1]Journal of Coordination Chemistry,2014,vol. 67,p. 2195 - 2203

52
[ 110-42-9 ]
[ 1002-62-6 ]

Reference： [1]Journal of Organic Chemistry,2018,vol. 83,p. 7398 - 7406

53
C₂₀H₄₂N₄O₄Pt₂⁽⁴⁺⁾*4NO₃^(1-) [ No CAS ]
[ 1002-62-6 ]
C₆₀H₁₁₀N₄O₈Pt₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In water; at 55℃; for 24h;Darkness;	General procedure: To a stirred suspension of [Pt2I4L] (0.32 g, 0.5 mmol) in water (100 mL), a solution of AgNO3(0.17 g, 1.0 mmol) in water (20 mL) was added. Under a nitrogen atmosphere, the mixturewas heated at 60 C for 24 h in the dark and the resulting AgI deposit was removed by filtration.Then corresponding sodium carboxylate (0.08 g, 1.0 mmol) aqueous solution was addedto the filtrate. The mixture was stirred at 55 C for 24 h in the dark. The filtrate was concentratedto 5 mL by rotary evaporation and then placed in a refrigerator overnight during whichtime a white solid precipitated. The precipitate was filtered and washed with cold distilledwater, cold ethanol and ether several times, and dried in vacuum. A white solid was obtained.Data for L1: Yield: 39%.

Reference： [1]Journal of Coordination Chemistry,2017,vol. 70,p. 3759 - 3768

54
[ 1002-62-6 ]
N-hydroxysulfosuccinimide sodium salt [ No CAS ]
C₁₄H₂₂NO₇S^(1-) [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
		General procedure: Fatty acid-free, globulin free, 66.2 kDa HSA was chosen for the backbone of the conjugates, based on a slight modification of previouspreparation methods [27]. This conjugation chemistry was based oncarbodiimide-mediated reaction where carbodiimide along with N-hydroxysuccinimide(NHS), acts as a cross-linker of the carboxyl group offatty acids with amine group of HSA molecule. The schematic mechanismof EDC/NHS coupling reaction is presented in Fig. 1. First, different types of fatty acid salt (10.0 mmol, depending on the molecular weight) and EDC (10.0 mmol, 192.16 mg) were dissolved in100 mL of MES buffer (pH 4.7) for 30 min at 80 C. Sulfo-NHS (10.0 mmol, 217.13 mg) was added in the presence of carboxylic-activated solutions. In this reaction, carbodiimide reacted with the carboxyli cgroup of fatty acids to form O-acylisourea active ester intermediate, which can react with amines to form a stable amide bond with HSA. Additionally, 1.0 g of HSA was dissolved in 100 mL of MES buffer (pH 4.7). MeOH (80 mL) was added to the HSA activating solution for 30 min. Activated fatty acid and HSA solution were mixed for 24 h at room temperature (25 C). After completion of the reaction, unreacted agents and intermediate products were dialyzed by distilled water for 2 days, following which lyophilized and HSA-fatty acid conjugates were obtained. Structural characterization of HSA and HSA fatty acid conjugates was confirmed by FT-IR and 1H NMR techniques. IR spectra of samples were measured by using ATR-FTIR spectroscopy (Nicolet iS50,Thermo Scientific, USA). FT-IR Samples were recorded over the range 4,000 to 400 cm-1 with a resolution of 4 cm-1 single scan. For 1H NMRexperiments, HSA and HSA-fatty acid conjugates were dissolved indeuterium oxide containing 1% deuterium chloride as a solvent at aconcentration of 1.0 mg/0.6 mL. 1H NMR spectra were recorded using aBruker ADVANCE 700 MHz spectrometer at 25 C (96 scans and 1.5 sdelay).

Reference： [1]European Journal of Pharmaceutics and Biopharmaceutics,2020,vol. 152,p. 257 - 269

55
[ 1002-62-6 ]
[ 70024-90-7 ]
human serum albumin decanoic acid conjugate [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In methanol; at 20℃; for 24h;pH 4.7;	General procedure: Fatty acid-free, globulin free, 66.2 kDa HSA was chosen for the backbone of the conjugates, based on a slight modification of previouspreparation methods [27]. This conjugation chemistry was based oncarbodiimide-mediated reaction where carbodiimide along with N-hydroxysuccinimide(NHS), acts as a cross-linker of the carboxyl group offatty acids with amine group of HSA molecule. The schematic mechanismof EDC/NHS coupling reaction is presented in Fig. 1. First, different types of fatty acid salt (10.0 mmol, depending on the molecular weight) and EDC (10.0 mmol, 192.16 mg) were dissolved in100 mL of MES buffer (pH 4.7) for 30 min at 80 C. Sulfo-NHS (10.0 mmol, 217.13 mg) was added in the presence of carboxylic-activated solutions. In this reaction, carbodiimide reacted with the carboxyli cgroup of fatty acids to form O-acylisourea active ester intermediate, which can react with amines to form a stable amide bond with HSA. Additionally, 1.0 g of HSA was dissolved in 100 mL of MES buffer (pH 4.7). MeOH (80 mL) was added to the HSA activating solution for 30 min. Activated fatty acid and HSA solution were mixed for 24 h at room temperature (25 C). After completion of the reaction, unreacted agents and intermediate products were dialyzed by distilled water for 2 days, following which lyophilized and HSA-fatty acid conjugates were obtained. Structural characterization of HSA and HSA fatty acid conjugates was confirmed by FT-IR and 1H NMR techniques. IR spectra of samples were measured by using ATR-FTIR spectroscopy (Nicolet iS50,Thermo Scientific, USA). FT-IR Samples were recorded over the range 4,000 to 400 cm-1 with a resolution of 4 cm-1 single scan. For 1H NMRexperiments, HSA and HSA-fatty acid conjugates were dissolved indeuterium oxide containing 1% deuterium chloride as a solvent at aconcentration of 1.0 mg/0.6 mL. 1H NMR spectra were recorded using aBruker ADVANCE 700 MHz spectrometer at 25 C (96 scans and 1.5 sdelay).

Reference： [1]European Journal of Pharmaceutics and Biopharmaceutics,2020,vol. 152,p. 257 - 269

Same Skeleton Products

Related Products

Historical Records

Related Functional Groups of
[ 1002-62-6 ]

Aliphatic Chain Hydrocarbons

[ 6106-41-8 ]

Sodium pentanoate

Similarity: 1.00

[ 13521-83-0 ]

Sodium glutarate

Similarity: 1.00

[ 408-35-5 ]

Sodium palmitate

Similarity: 1.00

[ 10051-44-2 ]

N-caproicacidsodiumsalt

Similarity: 1.00

[ 37435-69-1 ]

Sodium 5-hydroxypentanoate

Similarity: 1.00

Carboxylic Acid Salts

[ 6106-41-8 ]

Sodium pentanoate

Similarity: 1.00

[ 13521-83-0 ]

Sodium glutarate

Similarity: 1.00

[ 408-35-5 ]

Sodium palmitate

Similarity: 1.00

[ 37435-69-1 ]

Sodium 5-hydroxypentanoate

Similarity: 1.00

[ 822-16-2 ]

Sodium stearate

Similarity: 1.00

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 1002-62-6 ] {[proInfo.proName]}

Quality Control of [ 1002-62-6 ]

Related Doc. of [ 1002-62-6 ]

Product Details of [ 1002-62-6 ]

Calculated chemistry of [ 1002-62-6 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 1002-62-6 ]

Application In Synthesis of [ 1002-62-6 ]

[ 1002-62-6 ] Synthesis Path-Upstream 1~1

[ 1002-62-6 ] Synthesis Path-Downstream 1~55

Related Functional Groups of [ 1002-62-6 ]

Aliphatic Chain Hydrocarbons

Carboxylic Acid Salts

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 1002-62-6 ]